
    
      Recent research (Lancet Oncology 2012)shows that no survival benefits were achieved by adding
      adjuvant chemotherapy after concurrent chemoradiation in patients with locoregionally
      advanced NPC. But in patients with even high risk of distant metastasis(staged N2-3M0),is
      adjuvant chemotherapy necessary?
    
  